United Therapeutics Corporation (UTHR)
Debt-to-capital ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 6,444,000 | 6,100,900 | 5,697,200 | 5,338,100 | 5,984,800 | 5,712,100 | 5,411,000 | 5,123,200 | 4,796,700 | 4,562,200 | 4,318,400 | 4,176,300 | 3,958,900 | 3,829,700 | 3,639,500 | 3,445,400 | 3,395,200 | 3,283,100 | 3,093,700 | 2,948,500 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $6,444,000K)
= 0.00
The debt-to-capital ratio of United Therapeutics Corporation has consistently been reported as 0.00 since March 31, 2020, up to December 31, 2024. This indicates that the company has not utilized debt as a significant portion of its capital structure during this period. A debt-to-capital ratio of 0.00 implies that there is either no debt in the company's capital structure or the debt levels are negligible compared to the total capital employed. This could be indicative of strong financial discipline, low leverage, or a reliance on other sources of financing such as equity. It suggests that the company may have a conservative approach to managing its debt obligations and financial risks.
Peer comparison
Dec 31, 2024